BioMarin Pharmaceutical Inc (BMRN) Net income 2016–2025
BioMarin Pharmaceutical Inc (BMRN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$348.9MFY2025 · since FY2016: -$630.2M → $348.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $348.9M | -18.3% |
| FY2024 | $426.9M | +154.7% |
| FY2023 | $167.6M | +18.4% |
| FY2022 | $141.6M | +320.9% |
| FY2021 | -$64.1M | -107.5% |
| FY2020 | $854.0M | +3681.1% |
| FY2019 | -$23.8M | +69.1% |
| FY2018 | -$77.2M | +34.0% |
| FY2017 | -$117.0M | +81.4% |
| FY2016 | -$630.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice